-+ 0.00%
-+ 0.00%
-+ 0.00%

*Gossamer Bio Announces Up to $250M Structured Private Placement, Including $150M of Committed Cap, to Fund Seralutinib Through Potential FDA Approval

Dow Jones·08/21/2026 12:00:00

登錄查看新聞詳情